HomeEDSA • NASDAQ
add
Edesa Biotech Inc
Previous close
$5.07
Day range
$5.00 - $5.30
Year range
$2.46 - $8.33
Market cap
17.04M USD
Avg Volume
8.60K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 2.22M | -7.89% |
Net income | -1.86M | 20.26% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -2.18M | 8.74% |
Effective tax rate | -0.04% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 2.80M | -62.53% |
Total assets | 6.48M | -39.34% |
Total liabilities | 2.15M | 28.51% |
Total equity | 4.32M | — |
Shares outstanding | 3.22M | — |
Price to book | 3.78 | — |
Return on assets | -77.60% | — |
Return on capital | -107.73% | — |
Cash Flow
Net change in cash
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Net income | -1.86M | 20.26% |
Cash from operations | -1.66M | -5.60% |
Cash from investing | — | — |
Cash from financing | 211.70K | -72.31% |
Net change in cash | -1.47M | -83.76% |
Free cash flow | -1.35M | -84.69% |
About
CEO
Founded
2007
Headquarters
Website
Employees
16